Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Pigmented Lesion Assay | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Pharmacogenomics Testing | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Healthâ¢) | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: NRAS Genetic Testing | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Next-Generation Sequencing for Solid Tumors | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Solid Organ Allograft Rejection | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Minimal Residual Disease Testing for Cancer | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: MGMT Promoter Methylation Analysis | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Melanoma Risk Stratification Molecular Testing | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Inivataâ¢, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Envisiaâ¢, Veracyteâ¢, Idiopathic Pulmonary Fibrosis Diagnostic Test | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: EndoPredict® Breast Cancer Gene Expression Test | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: DecisionDx-UM (Uveal Melanoma) | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Breast Cancer Assay: Prosigna® | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Blood Product Molecular Antigen Typing | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | MolDX: Biomarkers in Cardiovascular Risk Assessment | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Wound and Ulcer Care | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Vitamin D Assay Testing | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Urine Drug Testing | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Trigger Point Injections (TPI) | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Treatment of Varicose Veins of the Lower Extremities | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Treatment of Males with Low Testosterone | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Transurethral Waterjet Ablation of the Prostate | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Transcranial Magnetic Stimulation (TMS) | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Total Knee Arthroplasty | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Total Hip Arthroplasty | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Spinal Cord Stimulators for Chronic Pain | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Serum Magnesium | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Sacroiliac Joint Injections and Procedures | Criteria changed |
| May 17, 2026 | Noridian Healthcare Solutions | Respiratory Care | Criteria changed |